Visual Defence wins Swedish deal

Emblaze subsidiary Visual Defence said Wednesday it won a $12m. contract from the City of Stockholm's Public Transport Company, SL, to supply its mobile video surveillance system on SL's fleet of buses.

By AVI KRAWITZ
June 29, 2006 07:20

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Emblaze subsidiary Visual Defence said Wednesday it won a $12m. contract from the City of Stockholm's Public Transport Company, SL, to supply its mobile video surveillance system on SL's fleet of buses. The deal follows a C$10m. contract Visual Defence signed with SL to install its control systems at the entrance and exit points of Stockholm's subway and bus stations. Now, the company, which has headquarters in Canada and Petah Tikva, will deploy some 10,000 cameras and 2,500 DVSSm storage devices on SL's 2,500 buses. Phase 1 will see the immediate deployment of the system on 100 buses, while the remainder will be installed in 2007.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS